See this page online at: http://www.bioscienceworld.ca/Discovery
Sign up for your subscription and keep up-to-date.
Stay updated on the latest news and technologies with Bioscienceworld's newsletters.
Five to choose from.
|
February 16 2011
Breakthrough treatment for blocked arteries Patients who have run out of treatment options for a common heart condition have found new reason for hope in the world’s first trial of a plaque-softening enzyme.
|
|
November 22 2010
Scientists discovery new methods for studying molecules Researchers at Queen’s University have discovered the method for studying oxygen in large molecular systems. The findings will help in the study of proteins, DNA, RNA and other molecular structures.
|
|
October 26 2010
Simon Fraser University seeds discovery of mutant gene in chromosomes Simon Fraser University molecular biologists have discovered a gene whose role is to ensure that chromosomes are correctly distributed during the formation of eggs and sperm in mammals, including humans.
|
|
October 26 2010
Flavelle medalist credits Carleton University Kenneth Storey, professor of Biology and Chemistry at Carleton and Canada Research Chair in Molecular Physiology, will be awarded the prestigious Flavelle Medal from the Royal Society of Canada next month.
|
|
October 26 2010
Family medicine professor leads $11.7 million project to help fight chronic disease A new, ground-breaking project led by a Queen’s University professor is going to improve the primary care management of Canadians battling five chronic diseases.
|
|
August 27 2010
Funding announced for technology upgrades for improved nuclear medicine at TRIUMF A federal investment of over $911,000 to support innovative medical and pharmaceutical research at TRIUMF through the Western Diversification Program is announced by the Honourable Lynne Yelich, Minister of State for Western Economic Diversification Canada.
|
|
August 12 2010
Breakthrough heralds era of personalized cancer treatment Simon Fraser University molecular biologist Stephen Jones is among the researchers leading the charge to deliver personalized therapies tailored to the genetic makeup of individual cancers.
|
|
February 16 2010
Electric field propels worms to test new drugs A Nobel-winning process for testing new drugs to treat diseases such as Huntington’s, Parkinson’s, and muscular dystrophy is getting an electrical charge.
|
|
February 16 2010
Allon’s davunetide treatment for schizophrenia patients proves promising The results of a Phase IIa clinical trial presented at a major scientific meeting indicate that Allon Therapeutics Inc. lead neuroprotective drug candidate davunetide achieved measurable positive treatment effects in schizophrenia patients with cognitive impairment.
|
|
December 03 2009
Biologist receives Sterling controversy prize Michael Worobey, an evolutionary biologist who pioneered highly controversial research into the origins of HIV/AIDS, is the 2009 recipient of Simon Fraser University’s Nora and Ted Sterling prize in support of controversy.
|
|
September 10 2009
Stem Cells coaxed into T Cells by Ontario researchers Institute have developed a way to coax human stem cells into becoming progenitor T cells.
|
|
June 18 2009
Canadian government supports research to help address medical isotope shortage The Honourable Leona Aglukkaq, Minister of Health, announces that the Canadian government is supporting research to find alternatives to nuclear-produced Technetium-99m.
|
|
June 08 2009
SFU chemist wins Woman of Distinction award Sophie Lavieri, a senior chemistry lecturer at Simon Fraser University, has won a 2009 YWCA Woman of Distinction award. The YWCA began the awards in 1984 “to honour, encourage and recognize women whose outstanding activities and achievements contribute to the health and future of the community.”
|
|
June 05 2009
Warnex launches test for Influenza A H1N1 virus Warnex Inc. announces that its Medical Laboratories division has launched a test for the detection of the influenza A H1N1 virus.
|
|
May 29 2009
Researchers devising blood test to diagnose organ rejection in transplant patients The launch of the second phase of Biomarkers in Transplantation involves an innovative translational research initiative that will eventually allow doctors to identify which patients rejecting a transplanted organ with a simple blood test.
|
|
May 25 2009
Mount Sinai researcher gives new hope for patients with liver disease In a study published by the New England Journal of Medicine online on May 20, 2009, (and in the June 11, 2009 print issue) Mount Sinai Hospital’s Dr. Katherine Siminovitch has discovered a new genetic pathway (a gene “road map”) that could provide personalized treatment options for patients with a devastating liver disease.
|
|
May 25 2009
Memorial University researchers involved in study aimed at unlocking the mysteries of aging Six Memorial University investigators are involved in a new federally funded study that will increase the understanding of common health problems affecting seniors.
|
|
May 11 2009
SFU prof helps combat deadly flu viruses A Simon Fraser University professor is part of a research team that has developed a new computational weapon that will destroy influenza viruses such as H1N1 (swine flu) and H5N1 (avian flu).
|
|
May 11 2009
Massage after exercise impairs blood flow - according to Queen’s University study A Queen's University research team has blown open the myth that massage after exercise improves circulation to the muscle and assists in the removal of lactic acid and other waste products.
|
|
May 08 2009
Canada’s top teen biotech scientists square off in National Competition finals Canada’s national science competition season began last week with the Sanofi-Aventis Biotalent Challenge, held at the Ottawa headquarters of the National Research Council of Canada.
|
|
April 27 2009
Cow genes elucidate evolution A Simon Fraser University-led research team’s analysis of the first genomic sequence of a mammalian livestock animal provides clues about cattle’s evolution.
|
|
April 16 2009
Genome Canada pulls out of consortium Genome Canada announces that it will not fund the next stage of the International Regulome Consortium (IRC), which will leave the project $18 million short of its anticipated budget.
|
|
April 09 2009
Research on Alzheimer’s disease wins grade 12 Surrey student entry to national biotech competition Innovative research by a 17-year-old Surrey BC, Sands Secondary School student that could lead to an improved treatment for Alzheimer’s disease has earned first place in the 2009 Sanofi-Aventis BioTalent Challenge (SABC) in the British Columbia region.
|
|
March 30 2009
Cytochroma announces new findings regarding the role of CYP24 in chronic kidney disease These findings suggest that abnormally increased expression of CYP24, the cytochrome P450 enzyme specific for catabolizing vitamin D, may be a key consideration in the management of secondary hyperparathyroidism (SHPT) in CKD.
|
|
March 27 2009
Lorus Therapeutics announces Ohio State University receives $2 million grant Lorus Therapeutics Inc. announces that researchers at the Ohio State University (OSU) have received a grant of approximately US $2 million to explore the potential for applying OSU's proprietary tumor-targeted nanoparticle drug delivery technology with ribonucleotide reductase (RNR) targeted RNA-based drugs.
|
|
March 19 2009
Cytochroma announces new findings Cytochroma announces new research findings demonstrating the increased expression of CYP24 in a preclinical model of chronic kidney disease (CKD).
|
|
March 16 2009
New standard helps eliminate toxic smoke in operating rooms The Canadian Standards Association (CSA) will announce a new standard designed to help eliminate toxic airborne contaminants, such as smoke, from operating rooms and other settings, later this week.
|
|
March 16 2009
Environmental contaminants may help beat breast cancer Simon Fraser University faculty of Health Sciences researcher, Tim Beischlag, has found that environmental contaminants such as dioxins and polychlorinated biphenyls (PCBs), which are known carcinogens, activate a key protein also found in the human body that can suppress breast cancer growth.
|
|
February 20 2009
New health research facility will improve drug and disease research in Nova Scotia A new Biomolecular Magnetic Resonance Facility at the National Research Council Institute for Marine Biosciences (NRC-IMB) will house the world's most sensitive magnetic resonance equipment for small samples, allowing universities, health-care providers, and private industry in Nova Scotia to work together in developing high-tech health-care solutions for all Canadians.
|
|
February 05 2009
Researchers close to turning urine into water Queen's University researchers are one step closer to turning human urine into drinking water. Developed for use in space, this discovery could allow for longer missions and larger crews.
|
|
December 23 2008
Treatment for men’s pelvic pain found ineffective A commonly prescribed drug for men suffering from a painful pelvic condition failed to significantly reduce patients' symptoms in an international study led by Queen's University professor and urologist at Kingston General Hospital, Curtis Nickel.
|
|
December 23 2008
CPhA warns parents and caregivers to talk to pharmacists about cough and cold medications in children Health Canada has advised that orally administered over-the-counter cough and cold products with certain active ingredients should only be used in children six years of age and older.
|
|
December 16 2008
In the animal world, bigger doesn’t always mean better New research shows that size isn’t always an advantage in the animal world, shattering a widely-held belief that bigger is always better.
|
|
December 15 2008
First of its kind young women’s breast cancer program launched Sunnybrook's Odette Cancer Centre starts a first-of-its-kind in Canada, PYNK: Breast Cancer Program for Young Women, for women 40 years or younger with breast cancer who studies indicate are more likely to recur and die of their disease than older patients and are at greatest risk of psychological and social distress.
|
|
December 15 2008
Urodynamix presents first data on use of NIRS and transurethral microwave therapy Urodynamix Technologies Ltd. presents an abstract highlighting the use of Urodynamix's near infrared spectroscopy (NIRS) technology for non-invasive measurement of blood flow changes during minimally invasive treatments for benign prostatic hyperplasia (BPH).
|
|
December 12 2008
McLaughlin-Rotman Centre for Global Health presents new research findings in Malaria Researchers from the McLaughlin-Rotman Centre for Global Health - Sandra A. Rotman Laboratories, led by Dr. Kevin Kain, are presenting two important new findings in the fight against malaria.
|
|
December 11 2008
Competing genes linked to... It turns out a genetic "tug-of-war" between a mother and father's genes may be behind such mental disorders as autism and schizophrenia.
|
|
December 11 2008
KGK Synergize supports new Vitamin D research KGK Synergize Inc. sponsors an observational screening study along with the Toronto Man to Man Prostate Cancer Support Group, to evaluate the vitamin D status of volunteers from Toronto.
|
|
December 11 2008
Ontario government turns over funds for research projects Research aimed at improving therapies for autistic children, breast cancer and improving treatments for heart and lung disease are among the innovative health care research projects receiving $21 million in funding from the province.
|
|
December 04 2008
Turning super bad bugs into benign bugs Simon Fraser University molecular biologist Fiona Brinkman and one of her graduate students, Morgan Langille, belong to a team of scientists who have shown that tiny bacterial viruses can confer superbug capabilities on bacteria.
|
|
November 28 2008
2008 Alberta bio-industry award winners announced BioAlberta announces the winners of the 2008 BioAlberta Achievement Awards at its 9th Annual General Meeting and Awards Gala.
|
|
November 28 2008
Amorfix successfully completes ALS drug discovery program Amorfix Life Sciences achieves the third and final milestone under the 2006 research, investment and option agreement with Biogen Idec to discover novel treatments for amyotrophic lateral sclerosis (ALS – Lou Gehrig's disease).
|
|
November 21 2008
LifeSciences British Columbia recognizes Dr. Michael Hayden, named Canada’s Health Researcher of the Year LifeSciences BC announces that one of British Columbia’s pre-eminent health researchers, Dr. Michael Hayden, director and senior scientist at the Centre for Molecular Medicine and Therapeutics, and University Killam Professor, Department of Medical Genetics at UBC has received the Canadian Institutes of Health Research’s (CIHR) Michael Smith Prize in Health Research: Canada's Health Researcher of the Year award.
|
|
November 21 2008
Queen's enzyme discovery may lead to better heart and stroke treatments A Queen's University study sheds new light on the way one of our cell enzymes, implicated in causing tissue damage after heart attacks and strokes, is normally kept under control.
|
|
November 17 2008
World’s top cancer research body sponsors landmark COLD-FX® trial CV Technologies Inc. announces that COLD-FX(R) will be the focus of a landmark U.S. National Cancer Institute (NCI) sponsored trial involving chronic lymphocytic leukemia patients - the first time the natural medicine will be part of a clinical study associated with cancer.
|
|
November 10 2008
Cell fossilizes in living humans It’s been deemed as a ‘mind-blowing’ discovery - a cell that fossilizes itself inside of us while we are still alive. The cell, known as the osteocyte, is one of the three bone cells. Millions of these cells live inside our bones.
|
|
November 10 2008
Unusual owl migration patterns observed Professor Erica Nol is doing her best to solve the mysteries behind the Northern Saw-whet owls (Aegoius acadicus).
|
|
November 10 2008
Road safety and dementia patients on psychotropic medication Older drivers with dementia who are prescribed psychotropic medication and/or exhibit psychiatric symptoms should be evaluated for road safety, says new research from the Institute of Clinical Evaluative Sciences (ICES), Ontario Ministries of Health and Transportation and Sunnybrook Health Sciences Centre.
|
|
November 03 2008
U of S scientists part of study that finds ‘rotten egg’ gas key to lowering blood pressure An international research team, with scientists from the University of Saskatchewan, has discovered that a gas produced in blood vessels regulates and lowers blood pressure.
|
|
October 24 2008
Thallion’s TLN-4601 inhibits mutated K-RAS signaling in cancer cells Thallion Pharmaceuticals Inc. announces that data presented by collaborators demonstrated TLN-4601 inhibits proliferation and signaling of mutated K-Ras expressing cancer cells.
|
|
October 24 2008
Urodynamix announces publication of two articles in Canadian Journal of Urology Urodynamix Technologies Ltd. announces that two peer-reviewed articles related to the application of its near infrared spectroscopy (NIRS) technology in urology have been published in the October 2008 edition of the prestigious Canadian Journal of Urology.
|
|
October 20 2008
Ambrilia reports positive results for the second clinical phase III study Ambrilia Biopharma Inc. repors positive 24-week extension Phase III ("Study 302") top line results for its proprietary prolonged-release formulation of octreotide C2L.
|
|
October 20 2008
Amorfix sets record as a world first Amorfix Life Sciences announces that its Disease Specific Epitope (DSE) monoclonal antibody treatments demonstrated statistically significant improvement in survival over controls in a mouse model of Amyotrophic Lateral Sclerosis (ALS).
|
|
October 17 2008
Bird study finds maternal stress ‘positive’ SFU researchers Oliver Love and Tony Williams and a team from Trent University discovered that hormones released by stressed mother starlings can actually improve the physical development of their offspring.
|
|
October 15 2008
Researchers find gene that causes dogs to collapse Researchers at the University of Saskatchewan’s Western College of Veterinary Medicine (WCVM) and the University of Minnesota’s College of Veterinary Medicine have identified a genetic mutation in Labrador retriever dogs that is highly associated with exercise-induced collapse (EIC) syndrome.
|
|
September 08 2008
Funding to search for ways to help 500,000 children breathe easier Merck Frosst Canada Ltd. is funding an asthma-related project initiated by the National Research Council of Canada (NRC). Earlier this year, Merck Frosst approved a proposal by a Charlottetown-based immunologist at the NRC Institute for Nutrisciences and Health.
|
|
September 05 2008
Theratechnologies announces publication in AIDS Theratechnologies’ 52-week results from its first Phase III clinical trial, using tesamorelin, have been published in the Sept. 2, 2008 Journal of the International AIDS Society (www.aidsonline.com).
|
|
August 25 2008
Transition Therapeutics strengthens drug discovery group Transition Therapeutics Inc. announces a series of actions to strengthen the company's drug discovery group. Transition has acquired certain assets and the exclusive rights to three drug discovery projects from Forbes Medi-Tech (Research) Inc., a wholly owned subsidiary of Forbes Medi-Tech Inc. In addition, Dr. John Nestor, has joined Transition Therapeutics (USA) Inc. as vice president of Drug Discovery.
|
|
August 25 2008
Theratechnologies reports on positive body image parameters Theratechnologies releases positive data related to body image for patients treated with tesamorelin in both its first and confirmatory Phase III clinical trials, in two poster presentations at the XVII International AIDS Conference in Mexico City, Mexico.
|
|
August 22 2008
Lorus Therapeutics announces identification of potential novel biomarker Lorus Therapeutics Inc announces publication by the California Cancer Consortium of a paper entitled "Identification of F-box/LLR-repeated Protein 17 a Potential Useful Biomarker for Breast Cancer Therapy" (Xiao et al. Cancer Genomics and Proteomics 2008; 5: 151-160).
|
|
August 12 2008
Researchers shed new light on human enzyme Researchers studying the little known role of a human enzyme are getting closer to understanding its activity - and its potential effect on the processes leading to diabetes and neurodegenrative disease.
|
|
August 12 2008
Biologists link locust comas with human migraine The way locusts react to stress may provide an important clue to understanding what causes human migraines - and how to reduce their painful effects, said Queen's Biology professor Mel Robertson.
|
|
August 12 2008
Thry'vors increases awareness about the 'Good Cancer' on the rise Many consider thyroid cancer to be the 'good cancer' or the best cancer you can get since the mortality rate is low.
|
|
July 28 2008
Solving mental health problems by turning research into action Funding of $4.4 million from the Canadian Institutes of Health Research (CIHR) was announced by Steven Fletcher, MP for Charleswood-St. James-Assiniboia and Parliamentary Secretary for Health, on behalf of Tony Clement, Minister of Health.
|
|
July 14 2008
Upstream and McGill University to collaborate on testing of potential tropical disease treatments Upstream Biosciences has entered into collaboration with McGill University's Institute of Parasitology in Montreal, Canada to begin in vitro testing of the company's second generation of drug candidates for the potential treatment of tropical diseases leishmaniasis, trypanaosomiasis and malaria.
|
|
July 02 2008
Ambrilia validates its targeted delivery technology for cancer in vivo Ambrilia Biopharma Inc. reports that it demonstrated and validated the in vivo proof-of-concept with its NGR-delivery technology applied to a carrier containing a siRNA (small interfering RNA).
|
|
July 02 2008
Allon Therapeutics human efficacy data to be featured at world’s leading Alzheimer's disease conference Allon Therapeutics Inc. has been selected to present a summary of its Phase IIa efficacy data in patients with amnestic mild cognitive impairment (aMCI), a precursor to Alzheimer’s disease, at a news conference of the International Conference on Alzheimer’s Disease and Related Disorders (ICAD 2008) in Chicago July 28, 2008.
|
|
June 13 2008
Respiratory research attracts $12 million In an effort to intensify research on what is causing an exponential increase in childhood asthma and allergies, two national research-funding agencies are investing $12 million in a cross-Canada exploration of the respiratory illnesses.
|
|
June 13 2008
Æterna Zentaris - article on Phase II Trial to be published in European Urology Journal Æterna Zentaris Inc. announces that the article titled “Placebo-controlled dose-ranging Phase II study of subcutaneously administered LHRH antagonist cetrorelix in patients with symptomatic benign prostatic hyperplasia (BPH”, has been accepted for publication in an upcoming issue of the European Urology Journal.
|
|
May 30 2008
Theratechnologies explores tesamorelin in growth hormone deficient abdominal obesity Theratechnologies announces a strategic agreement with both the Massachusetts General Hospital and Dr. Steven Grinspoon to explore the use of tesamorelin in relative growth hormone deficient abdominally obese (GHDAO) subjects. MGH, under the direction of Dr. Grinspoon, will sponsor and conduct a clinical trial with tesamorelin in subjects that have excess visceral adipose tissue (VAT) with a moderate growth hormone deficiency and who are abdominally obese.
|
|
May 05 2008
Chemokine Therapeutics announces positive data on lead product candidate CTCE-9908 Chemokine Therapeutics Corp. announces positive CTCE-9908 data results in the treatment of breast cancer in a preclinical model. Results were presented by Dr. Mark Basik of McGill University, at the American Association for Cancer Research (AACR) Annual Meeting in San Diego, CA.
|
|
April 21 2008
GeneNews reports positive results from validation study of colorectal cancer biomarkers GeneNews Limited reported positive performance results from a large validation study of a six-gene biomarker panel for the assessment of a patient's current risk for colorectal cancer.
|
|
April 21 2008
ARIUS presents new findings for anti-cancer antibody programs at AACR ARIUS Research Inc. reports new data and program updates related to its CD44, TROP-2, CD59, and CD9 antibody programs at the American Association for Cancer Research (AACR) Annual Meeting.
|
|
April 18 2008
MethylGene presents clinical biomarker data for MGCD0103 MethylGene Inc. presents clinical biomarker data for its isoform-selective histone deacetylase (HDAC) inhibitor, MGCD0103, as well as preclinical efficacy data when administered in combination with taxanes.
|
|
April 04 2008
Breakthrough improves brain-function understanding Two SFU neuroscientists have made a major breakthrough in human brain-function research that opens the door to discovering brain activity as it is happening. It offers a promising new way to investigate disorders, including autism, dementia, depression and anxiety.
|
|
March 24 2008
Osta’s new experimental drug for prostrate cancer shows promise as an anti-metastatic drug Osta Biotechnologies Inc. announces promising results of a pre-clinical efficacy study on its lead anti-cancer therapeutic agent OB-24.
|
|
March 20 2008
Allon’s Phase II clinical trial shows statistically significant efficacy on human cognition and memory Allon Therapeutics Inc. releases top-line results of a Phase IIa clinical trial showing that its drug AL-108 has a positive impact on memory function in patients with amnestic mild congnitive impairment (aMCI), a precursor to Alzheimer’s disease (AD).
|
|
March 13 2008
Pharma's New Worldview: Transforming R&D Through Emerging Markets To date, research and development (R&D) in the pharmaceutical industry has been dominated by a developed markets perspective. But as emerging markets change pharmaceutical companies’ worldview, its time for drug makers to fundamentally rethink how R&D is done.
|
|
March 12 2008
Proteomics: An Expensive Science Proteomics is the study of the structure and
function of protein, just as every living thing has a complete set of DNA known as its genome, people all carry a full complement of proteins known as the proteome. In Canada, the benefits from proteomic research have been felt in such areas as healthcare, agriculture, forestry and the environment. The understanding gained from it has lead to new insights into how different diseases might be prevented, diagnosed and treated. |
|
March 07 2008
Vasogen provides update on ACCLAIM II program Vasogen Inc. provides an update on ACCLAIM II, a clinical trial which is being planned to support an application for U.S. market approval of the Celacade(TM) System.
|
|
February 25 2008
Amorfix presents results from British blinded panel of spiked human blood samples Amorfix Life Sciences Ltd. presents the decoded results of a blinded panel of spiked human blood samples, tested by Amorfix’s EP-vCJDTM assay, at the 12th Annual Transmissible Spongiform Encephalopathies international conference.
|
|
February 08 2008
GeneNews publication confirms blood-based colorectal cancer biomarker results GeneNews Limited announces the publication of a paper entitled "Novel Blood-Based, Five-Gene Biomarker Set for the Detection of Colorectal Cancer."
|
|
February 08 2008
New therapeutic target for the treatment of multiple sclerosis A new study provides answers about the role of novel adhesion molecules in the pathogenesis of multiple sclerosis (MS) and suggests new therapeutic targets for its treatment.
|
|
February 08 2008
Oncolytics announces issuance of 8th Canadian Patent Oncolytics Biotech Inc. is granted Canadian Patent 2,408,251 entitled “Clearance of Neoplastic Cells from Mixed Cellular Compositions using Viruses.”
|
|
January 30 2008
Thallion demonstrates ECO 4601 crosses the blood brain barrier and selectively targets brain tumours Thallion Pharmaceuticals Inc. has presented data from a brain tumour model demonstrating that ECO-4601 crosses the blood brain barrier and preferentially targets and accumulates in glioblastoma (brain) tumours.
|
|
January 24 2008
Osta announces promising pre-clinical results on a new experimental drug for prostate cancer Osta Biotechnologies Inc. announces the results of a pre-clinical efficacy study on its lead anti-cancer therapeutic agent OB-24 in a highly tumorigenic and metastatic human prostate cancer PC-3M xenograft mouse model.
|
|
January 14 2008
Protox announces positive final results from BPH study Protox Therapeutics Inc. announces positive final results from its Phase I study evaluating PRX302 in patients with benign prostatic hyperplasia (BPH), a common condition among the aging male population.
|
|
December 10 2007
Ottawa researchers awarded $266,000 toward finding a cure for Parkinson's The University of Ottawa and the Ottawa Health Research Institute are proud to announce several of its researchers have been awarded grants from Parkinson Society Canada (PSC), supporting important work in finding a cure for Parkinson's disease.
|
|
December 10 2007
Amorfix discovers common link between ALS and Alzheimer's Disease Amorfix Life Sciences announces the discovery of misfolded superoxide dismutase 1 (SOD1) protein in the brains of people with Alzheimer’s Disease. This breakthrough result suggests that SOD1 is a common link between the two brain-wasting diseases, Alzheimer’s and ALS, also known as Lou Gehrig’s Disease.
|
|
December 04 2007
Emerging Biotechnologies to Exploit Alternative Aplicing In the Treatment of Disease One of the surprising discoveries following the sequencing of the human genome was the relatively modest number of protein-coding genes, currently estimated at approximately 25,000.
|
|
November 26 2007
ARIUS presents non-traditional approach to drug discovery ARIUS presents its non-traditional approach to drug discovery using its proprietary FunctionFIRST technology at the 14th Annual BioNorth Biotechnology and Life Sciences Conference.
|
|
November 26 2007
Novel new drug discovery may revolutionize treatment of inflammatory disease and Leukemia Two Vancouver Coastal Health Research Institute (VCHRI) and University of British Columbia investigators have found a way to turn on the brakes of a cell, and thus halt abnormal blood-cell growth in a range of inflammatory and autoimmune disorders and blood cancers.
|
|
November 20 2007
Medical Ventures Corp. - pilot study suggests Metricath is effective in renal artery procedures Medical Ventures Corp. announces that its Metricath Libra® arterial and in-stent measurement system was shown in a pilot study to be effective for use in renal arteries, according to results shared at the New Cardiovascular Horizons (NCVH) conference in New Orleans.
|
|
November 12 2007
Amorfix Life Sciences’ test detects scrapie prions in blood of scrapie-infected sheep Amorfix Life Sciences announces the results from the testing of a blinded panel of blood samples from scrapie infected sheep. Amorfix correctly identified 18 out of 20 individual sheep blood samples.
|
|
November 12 2007
ARIUS announces new findings in Trop-2 and CD59 cancer antibody programs ARIUS Research Inc. announces that new findings have been presented from its Trop-2 and CD59 antibody programs demonstrating novel approaches to treating cancer.
|
|
October 26 2007
Osta Biotechnologies announces breakthrough results on new experimental cancer drug Osta Biotechnologies announces breakthrough results on its lead anti-cancer therapeutic agent OB-24 in pre-clinical studies on human cancer cells implanted in mice.
|
|
October 12 2007
Chemokine Therapeutics Corp. announces that abstract has been accepted for presentation Chemokine Therapeutics Corp. announces that an abstract, entitled "Anti cancer effect of a combination of CXCR4 antagonist CTCE-9908 and Docetaxel in a murine model of human prostate cancer", submitted by the company has been accepted by the American Association for Cancer Research ("AACR") for presentation at the Molecular Targets and Cancer Therapeutics International Conference.
|
|
September 04 2007
GeneNews chief scientist co-editor of new genomics reference book GeneNews Limited, a company focused on developing patient-friendly blood-based biomarker tests for the detection and staging of virtually any disease or medical condition, announces that its co-founder and Chief Scientist Dr. C.C. Liew, has co-edited a newly published genomics reference book entitled Cardiovascular Genetics and Genomics for the Cardiologist.
|
|
August 30 2007
Discovery may help defang viruses Researchers may be able to tinker with a single amino acid of an enzyme that helps viruses multiply to render them harmless, according to molecular biologists who say the discovery could pave the way for a fast and cheap method of making vaccines.
|
|
August 20 2007
InNexus Biotechnology unveils new platform for augmenting antibody therapeutics InNexus Biotechnology Inc. announces that significant enhancement of critical performance factors for many monoclonal antibodies (MAbs) appears possible through a novel cross linking technology developed by the company.
|
|
August 20 2007
Revolutionary biotherapeutic discoveries unveiled at 2007 Crossroad of Biotechnology Over 300 leaders from the pharmaceutical and biopharmaceutical industries recently gathered in Montreal to hear about the latest discoveries and trends in research and commercial applications in the rapidly emerging field of protein-based therapeutics at the 2007 Crossroad of Biotechnology.
|
|
August 14 2007
Canadian company Microbix' discovery could save many lives in flu pandemic A small Toronto based company's discovery has enormous implications for defending the human population from the next deadly outbreak of influenza.
|
|
July 31 2007
Drug gives new hope in treating symptoms of severe Alzheimer's A renowned neurology researcher at Sunnybrook has led an international community study, which shows an existing drug can help safely treat symptoms in more severe stages of Alzheimer's disease (A.D.).
|
|
July 31 2007
Enzyme discovery sheds light on vitamin D Findings by Queen's researchers shed new light on how the 'sunshine vitamin' D - increasingly used to treat and prevent cancer and other diseases - is broken down by people's bodies.
|
|
July 23 2007
Ontario leads cancer breakthrough Published this week in Nature Genetics, a global team of scientists led by MaRS tenant the Ontario Institute for Cancer Research as well as Cancer Care Ontario reported that they found the first genetic predictor for colorectal cancer, the second leading cause of cancer in Canada. This is good news especially for those living in Ontario, which has one of the highest incidences for colorectal cancer in the world.
|
|
July 06 2007
Modified mushrooms may yield human drugs Mushrooms might serve as biofactories for the production of various beneficial human drugs, according to plant pathologists who have inserted new genes into mushrooms.
|
|
June 25 2007
Resverlogix collaborates NexVas(TM) AD program with leading Alzheimer's researcher Resverlogix Corp. signs a collaborative research agreement with Dr. Larry Sparks of the Sun Health Research Institute (SHRI) to study Resverlogix's novel ApoA-I enhancing therapy for the treatment of Alzheimer's Disease (AD).
|
|
June 25 2007
Study finds blood glucose measurement by non-invasive monitor just like lab analysis Biosign Technologies Inc. releases the results of a study showing that blood glucose measurements from its unique, non-invasive monitoring system are not significantly different from laboratory blood analysis.
|
|
June 25 2007
McDonald and SNO team win Franklin Medal Queen's physicist Art McDonald and his team of scientific sleuths from the Sudbury Neutrino Observatory (SNO) win another prestigious international award for their groundbreaking discoveries about the nature of matter and the structure of the universe.Â
|
|
June 14 2007
London scientists explore new radiation delivery technology for cancer treatment For approximately 100 years, radiation therapy has been a vital tool in the treatment of cancers. The June issue of the International Journal of Radiation Oncology, Biology and Physics explains how London researchers are continuing to perfect the accuracy and efficacy of this therapy for the benefit of patients and clinicians.
|
|
May 28 2007
Potential anti-inflammatory drug secures award for U of S researchers A new drug with the potential to treat a wide array of inflammatory conditions has secured this year's Award of Innovation for two University of Saskatchewan researchers.
|
|
May 11 2007
Sentinel lymph node in cervical cancer reduces complications In the uncommon application of Sentinel Lymph Node (SLN) procedure to cervical cancer, Sunnybrook researchers have further validated its application as safe and practical in the treatment of the disease according to a study published in Gynecologic Oncology.
|
|
April 25 2007
AEterna Zentaris discloses In Vivo data for its GHRH Antagonist JMR-132 AEterna Zentaris Inc. has presented an abstract outlining in vivo data for its growth hormone-releasing hormone (GHRH) antagonist JMR-132 in breast cancer, at the American Association for Cancer Research (AACR) Annual Meeting.
|
|
April 18 2007
Functional Genomics and Proteomics in Personalized Medicine By Eef Harmsen, PhD, Rob Sladek, MD and Dr. Andrew Orr, MD
21st Century Approaches to Complex Diseases What is personalized medicine? Personalized medicine is not new. When your doctor tells you that your cholesterol is too high, that you need to lose weight and that you should stop smoking, he or she is giving you personalized advice, tailored to your specific situation, that will help you reduce your chances of having a heart attack or stroke. |
|
April 13 2007
Predicting harm in older cognitive patients Researchers at Sunnybrook Health Sciences Centre say they have identified areas of neuropsychological function that may cause self-neglect in cognitively impaired seniors living alone.
|
|
April 13 2007
Scientists make advances on genetic basis of autism The Canadian Autism Genome Project (CAGP), funded by the Ontario Genomics Institute (OGI) and led by Dr. Stephen Scherer of The Hospital for Sick Children, have discovered a previously unidentified chromosomal region containing genes associated with Autism.
|
|
April 02 2007
Inimex product candidate is first immune defense regulator to cure infections without causing harmful inflammation Inimex Pharmaceuticals Inc.'s product candidate IDR-1 is the first immune system trigger to cure infections without causing harmful inflammation, according to a paper published in the April 2007 issue of Nature Biotechnology.
|
|
April 02 2007
UBC discovery may lead to 'smart' therapies for breast, ovarian cancer New non-toxic and targeted therapies for metastatic breast and ovarian cancers may now be possible, thanks to a discovery by a team of researchers at the University of British Columbia.
|
|
March 19 2007
Sperm protein discovered at Queen's University may boost the success rate of in-vitro fertilization A Queen's University researcher has been awarded $142,000 from the Canadian Institutes of Health Research Proof of Principle program to develop a protein that may help to treat male infertility.
|
|
March 12 2007
Canada Wide Study to Look at SSRI Antidepressants Nearly 20 per cent of cardiac patients suffer from major depression, which may have a significant negative impact on the outcome of the cardiac disease.
|
|
March 12 2007
Vision Study Answers Question that has Vexed Scientists for Years Reaching for your morning coffee may feel like the simplest part of your day, but a new study led by York University Psychology Professor Doug Crawford reveals it relies on a critical brain mechanism that matches vision to action.
|
|
March 09 2007
Discovery gives new hope for advanced breast cancer sufferers A surprising discovery made by Queen's University researchers that happened when their work took an unexpected turn, may end up helping women with advanced breast cancer respond better to conventional drug treatments.
|
|
March 02 2007
CIHR-funded research reveals new implications for women using antidepressant medication CIHR-funded study shows a difference in alcohol consumption habits between women and men taking antidepressants. The research conducted by the Centre for Addiction and Mental Health (CAMH) concluded that women suffering from depression consumed more alcohol than women who did not experience depression, regardless of antidepressant use.
|
|
February 22 2007
Bill Gates' makes more than just a donation The Bill and Melinda Gates Foundation is contributing $28 million, and five federal departments a total of $111 million, to accelerate Canada's contribution to the global research and testing for an HIV vaccine. The impact on the biotech industry will be massive.
|
|
February 22 2007
OGI-funded scientists publish key advances on genetic basis of autism Canadian Autism Genome Project, funded by the Ontario Genomics Institute (OGI) and led by Dr. Stephen Scherer of The Hospital for Sick Children (Toronto), has discovered - as part of the international Autism Genome Project consortium - a previously unidentified chromosomal region containing genes associated with autism.
|
|
February 19 2007
Allon Therapeutics releases virtual animation to display how its drug works Over the course of 2006 Allon Therapeutics published numerous times how their drug works and the underlying mechanism of action.
|
|
February 19 2007
Leading researchers and experts will gather to discuss latest advancements in drug discovery The Society for Biomolecular Sciences (SBS) will gather in Montreal from April 15-19 to discuss the latest findings and research on advancements in biotechnology and drug discovery.
|
|
February 19 2007
Prize winning team unlocks secrets of viruses and other biomolecules A team of researchers based at the University of Manitoba, along with their collaborators at MDS Sciex and Agriculture and Agri-Food Canada, have won the third annual Brockhouse Canada Prize for Interdisciplinary Research in Science and Engineering. The prize includes $250,000 in funding for future research activities.
|
|
February 02 2007
Giving nitroglycerin to women in premature labour improves their babies' health, Queen's study shows A Queen's-led study shows that giving nitroglycerin to women who enter labour early results in significant improvement to their babies' health. The improvement is most marked in babies who are born very prematurely (at 24 to 28 weeks).
|
|
January 30 2007
Estrogen therapy for hot flushes challenged: progestin as effective as risk-laden estrogen Women seeking treatment for hot flushes can avoid health risks associated with estrogen by taking medroxyprogesterone, now demonstrated to be equally as effective as estrogen, according to research led by a University of British Columbia endocrinologist, who is also a member of the Vancouver Coastal Health Research Institute (VCHRI).
|
|
January 10 2007
STEM CELLS--science, ethics and politics at the forefront of biomedical innovation In the early 1960s, two researchers at the Ontario Cancer Institute in Toronto performed a series of experiments that led to a remarkable discovery - and the 2005 Lasker Award for Basic Medical Research.
|
|
November 27 2006
FDA approves Enzon application The U.S. Food and Drug Administration has completed a review of an investigational new drug (IND) application by Enzon Pharmaceuticals Inc. for the use of recombinant human Mannose-Binding Lectin (rhMBL) for the prevention and treatment of severe infections in patients with low levels of MBL undergoing liver transplant treatment.
|
|
November 21 2006
Liponex research collaborators present data on CRD5 mechanism of action Liponex Inc., a biopharmaceutical company specializing in developing advanced prodaucts related to High Density Lipoprotein (HDL), often called good cholesterol, announced that a presentation by Shawn Hopewell and colleagues from the University of Ottawa Heart Institute entitled Phosphatidylinositol acts through mitogen and stress activated protein kinase pathways to stimulate secretion of apoA-I was made yesterday at the American Heart Association 2006 Scientific Sessions held in Chicago, IL.
|
|
November 01 2006
Gastric cancer survival affected by poor assessment of lymph nodes Dr. Natalie Coburn, a surgical oncologist at Sunnybrook Regional Cancer Centre has found that fewer than one-third of gastric cancer patients have adequate lymph node assessments
|
|
November 01 2006
Study to evaluate ultrasound in prostate treatment A clinical study by the Lawson Health Research Institute is investigating if High Intensity Focused Ultrasound (HIFU) has the potential to treat prostate cancer with few side effects and minimal invasion.
|
|
October 02 2006
Researcher Finds Target to Restore T-Cell Function A team of scientists from the University of Montreal and the Centre Hospitalier de l'Université de Montréal (CHUM) has identified a defect in the immune response to HIV.
|
|
October 02 2006
Bovine Genome Offers Help for Human Research Researchers from the Bovine Genome Sequencing Project have made available on international public databases the most complete and accurate genome sequence to date, an upgraded genetic map, and a new set of two million DNA base differences for use as DNA sequence polymorphisms.
|
|
October 02 2006
UBC Team Identifies Possible Treatment for Alzheimer's, Down's Syndrome Dementia A team led by Dr. Weihong Song, PhD of the University of British Columbia and Vancouver Coastal Health Research Institute has identified new possibilities for treating Alzheimer's disease and dementia in Downs syndrome (DS) patients.
|
|
October 02 2006
Older Blood Clot Treatment as Good as New Dr. Clive Kearon, PhD, professor of medicine at McMaster University has found that treating venous thromboembolism with unfractionated heparin injected subcutaneously works just as well as subcutaneous injections of more expensive, low-molecular-weight heparin.
|
|
September 29 2006
Researcher Finds Target to Restore T-cell Function A team of scientists from the University of Montreal and the Centre Hospitalier de l'Université de Montréal (CHUM) has identified a defect in the immune response to HIV.
|
|
September 19 2006
Overweight Toddlers May Mean Overweight Youth While everyone things a pudgy baby is cute, parents may have reason to be concerned if they have a pudgy toddler.
|
|
September 13 2006
DDT Exposure Shrinks Bird Brains Researchers at the University of Alberta have uncovered the first proof that natural exposure to a contaminant damages the brain of a wild animal.
|
|
September 08 2006
A Step Closer to Tailored T-cell Therapy Researchers at Sunnybrook Health Sciences Centre have made a discovery that could lead to tailored T-cell therapy for those with immune system deficiencies.
|
|
September 08 2006
Pain Medication, Injuries Linked Researchers with the University of Alberta have found that older farmers are at high risk for injury when they stop taking prescription pain medication.
|
|
September 05 2006
Juice Reduces Alzheimer's Symptoms Maybe adults should take a lesson from kids by adding a juice box into their lunch routine.
|
|
August 29 2006
$1.3M to Avian Flu Vaccine Development A $1.3-million US grant will fund the production of a new avian flu vaccine.
|
|
August 22 2006
Lyme Disease Mechanism Uncovered A discovery made by researchers from the La Jolla Institute for Allergy & Immunology (La Jolla, CA) could lead to a vaccine for Lyme disease.
|
|
August 14 2006
Fidgeting Good for the Waistline If youre having trouble shedding some pounds, take heart. New research shows that losing weight may all be in your head.
|
|
August 09 2006
UBC Team Uncovers Cure for Huntington's Disease in Mice Researchers from the University of British Columbia's Centre for Molecular Medicine and Therapeutics, led by Michael Hayden, PhD, have been able to cure Huntington's disease (HD) in mice.
|
|
August 09 2006
To AIRE is Human, Researchers Find Research conducted by Terry Delovitch, PhD and colleagues from the Robarts Research Institute explains the role of a gene that may be essential to controlling autoimmune diseases such as Type 1 diabetes.
|
|
August 08 2006
Shampoo Contains Chemical that Affects Brain Development Could shampooing be dangerous?
No, say researchers from the University of North Carolina |
|
August 02 2006
Discovery Demonstrates Prostate Cancer Resistance To Drugs A discovery made by researchers from Wake Forest University (Winston-Salem, NC) has uncovered why prostate cancer cells become resistant to hormone therapy.
|
|
July 25 2006
Food Allergy Protein Found A study conducted at the Mount Sinai School of Medicine (New York, NY) has uncovered a protein that may be responsible for causing food allergies.
|
|
July 17 2006
Screening Method Effective in Detecting Breast Cancer A method for screening bodily fluids for certain types of cells and their genetic blueprint has recently been discovered to be twice as effective at detecting breast cancer cells as traditional microscope methods.
|
|
July 05 2006
McGill Researchers Uncover Bacterial Process A discovery made by researchers at McGill University (Montreal, QC) has significantly increased our understanding of a process that is essential to bacterias survival, and could open the door to the development new drugs that target antibiotic resistance.
|
|
June 30 2006
Molecule Blocks Immune System in Kidney Cancer Researchers at the Mayo Clinic (Rochester, MN) have discovered a molecule that blocks the immune system, and greatly increases a kidney cancer patient's risk of dying.
|
|
June 26 2006
Women More Influenced by Environment When Taking Up Smoking A recent study by researchers from the University of Southern California (Los Angeles, CA) has revealed that women are more influenced by environmental factors than men when it comes to taking up smoking.
|
|
June 19 2006
Brain Disease Gene Identified A team of researchers from the Oregon Health & Science University (Portland, OR) have discovered a gene that is responsible for a group of rare childhood disorders associated with iron buildup in the brain.
|
|
June 12 2006
Exercise Improves Blood Glucose in Diabetic Kids Kids with Type I diabetes might do well to get out of the house and play at the park.
|
|
June 05 2006
Sugar Makes Us Sleepy We all know that indulging in a big lunch often means having to spend the afternoon fighting the urge to have a nap.
|
|
May 19 2006
Angiogenesis Switch Uncovered A switch within cells that controls new blood vessel growth could be they key to developing more targeted drugs for a variety of eye-related diseases, according to research from the Boston, Mass.-based Schepens Eye Research Institute.
|
|
May 15 2006
Two Genes Increase Heart Attack Risk A large-scale study involving researchers from the University of California, San Francisco (San Francisco, CA), the Cleveland Clinic (Cleveland, OH) and Celera Genomics (Rockville, MD) has revealed that two gene variants play a role in increasing one's risk for early heart attack.
|
|
May 08 2006
New Gene Could Lead to Better Diabetes Understanding Research out of the University of Wisconsin-Madison (Madison, WI) has uncovered a gene that may play an important role in the development of Type 2 diabetes.
|
|
April 30 2006
Inflammation Enzyme Increases Infection Risk An enzyme that appears to modulate inflammation and innate immunity in humans may increase one's risk for bacterial infection or septic shock.
|
|
April 24 2006
Hormone Therapy Benefits Women in Their 50s A recently released study sheds new light on the continuing debate over the benefits and risks of hormone replacement therapy (HRT).
|
|
April 18 2006
Starfish Cousin Offers Model for Stem Cell Research Researchers at the Royal Swedish Academy of Sciences Kristineberg Marine Research Station have a new aquatic assistant in stem cell research.
|
|
April 10 2006
Honey Heals Instead of putting a little honey in your tea, you may want to put it in your first aid kit.
|
|
March 27 2006
Sleeping Patterns Affect Diabetes Risk in Men Men may want to reconsider before pulling another all-nighter, and should be equally wary of sleeping in late the next day.
|
|
March 23 2006
Brain Discovery Could Combat Drug Addiction A new discovery led by University of Saskatchewan (Saskatoon, SK) researchers has not only unveiled a signaling pathway in the brain linked to drug addiction, but also a method for blocking it.
|
|
March 22 2006
Melatonin Doesn't Help Sleep If you're having trouble sleeping, dont look to melatonin for help.
|
|
March 22 2006
Mother's Behaviour Affects Children's Genetics A team of researchers from McGill University (Montreal, QC) has discovered that a mother's behaviour during her child's early development can have an effect on the child's genes.
|
|
March 22 2006
Brown Rice May Be Good For Your Heart Though white rice is more popular, it may be healthier to have brown rice with your serving of moo shu pork.
|
|
March 22 2006
Internet Helps Cancer Patients Cope The Internet isn't just a place to download music and movies, it can greatly affect a cancer patient's attitude toward their medical care, a recent study from Temple University (Philadelphia, PA) researchers shows.
|
|
March 20 2006
Antidepressant's Usefulness Depends on Genetics It turns out that medication may not be the answer for everyone when seeking help for depression.
|
|
March 07 2006
Spinal Protein Could Aid MS Detection Researchers from Johns Hopkins University (Baltimore, MD) may be able to develop a test that will help identify a subset of multiple sclerosis (MS) patients, thanks to their recent discovery.
|
|
March 02 2006
Dirt Could Aid Understanding of Antibiotic Resistance Unlocking the secrets of antibiotic-resistant bacteria is a dirty job, but somebody has to do it- and researchers at Hamilton-based McMaster University have stepped up to the challenge.
|
|
March 02 2006
Broccoli Could Provide Lifelong Heart Disease Protection Parental advice about remembering to eat ones broccoli may be best suited to an expectant mother as opposed to a child, according to a recent study from the University of Saskatchewan (U of S) (Saskatoon, SK).
|
|
March 02 2006
Pregnancy Disorder Gene Identified Researchers at the McGill University Health Centre (MUHC) (Montreal, QC) have uncovered the underlying genetic cause of molar pregnancy, a condition that can develop into cancer.
|
|
March 02 2006
Air Pollution Could Increase Heart Attack Risk A University of Alberta (Edmonton, AB) researcher has uncovered a possible link between diesel exhaust or power plant emissions and cardiovascular risk in obese, pre-diabetic individuals.
|
|
February 27 2006
Taste Receptor Cells Grown Outside the Body For the first time ever, researchers have successfully grown mature taste receptor cells outside of the body and kept them alive for a sustained period of time, opening the door to a better understanding of our sense of taste.
|
|
February 20 2006
Researchers Extend Stem Cell Life Though stem cells hold promise as therapeutic agents, their use is also fraught with complications.
|
|
February 06 2006
Pre-eclampsia Biomarker Found A common but dangerous pregnancy complication can now be identified by analyzing proteins found in urine, according to a recent study by Yale University (New Haven, CT) researchers.
|
|
February 06 2006
Cardiovascular Biomarker Also Indicates Vision Troubles A known cardiovascular disease biomarker may also indicate one's risk for age-related macular degeneration (AMD), a U.S. study has recently revealed.
|
|
February 06 2006
Nervous System Protein Discovered A protein essential to the proper development of the nervous system has been discovered by a collaboration of researchers from the Hospital for Sick Children (Toronto, ON), the University of Toronto (Toronto, ON) and Cold Spring Harbor Laboratory (Cold Spring Harbor, NY).
|
|
February 06 2006
Coffee May Reduce Breast Cancer Risk For many, a morning cup of joe is an essential pick-me-up. For a select group, it could also be a lifesaver.
|
|
January 23 2006
Vitamin A May Prevent Lung Cancer In case you needed another reason to take your vitamins, researchers at Washington University (St. Louis, MO) have discovered that a vitamin A-related compound could potentially prevent or slow tumour growth in those with a predisposition to cancer.
|
|
January 16 2006
Smoking While Pregnant Could Cause Deformities in Child Women who smoke during pregnancy put their children at a higher risk of developing finger- and toe-related deformities, according to a recently published study.
|
|
January 01 2006
Canada Honours Top Health Researchers Canada's leading health researchers were recognized for their efforts at the fourth annual Canadian Health Research Awards gala.
|
|
January 01 2006
CANVAC Uncovers New Weapon Against HIV Canadian researchers have discovered an immune system stimulation method that could lead to an effective new therapeutic for HIV patients.
|
|
January 01 2006
Immunity Project Receives $17M in Funding The battle against microbial pathogens and infectious diseases has just received a $17-million boost courtesy of Genome Canada (Ottawa, ON) and Genome BC (Vancouver, BC).
|
|
December 07 2005
Inflammation Causes Persistent Pain Inflammation can be a pain in the neck. Not only does it cause discomfort, but now researchers say it may affect how long a patient suffers from chronic pain.
|
|
October 25 2005
Engineers Team Up To Uncover Red Blood Cell Mysteries A new study combining the expertise of two very different types of engineers may have uncovered the key to a red blood cell's unparalleled flexibility.
|
|
September 20 2005
Virus-prevention Mechanism of Compound Revealed A small battle in the war against viruses appears to have been won.
|
|
September 06 2005
Genetic Mutation Increases Cancer Risk in Men A new study shows a gene mutation that causes an increased breast cancer risk in women may also boost men's cancer risks.
|
|
August 19 2005
Age-related Protein Could Hold Key to New Diabetes Therapies Researchers at the Washington University School of Medicine (St. Louis, MO) have made a discovery that could lead to the development of more effective Type 2 diabetes treatments.
|
|
August 15 2005
Tadpoles Can Be Used for Lymph Research A recent study has revealed that studying tadpoles may accelerate research of the human lymphatic vessel network, which could lead to more effective cancer treatments.
|
|
August 08 2005
Key Alzheimer's Discovery Could Lead to New Treatment A group of international researchers has found what it deems a "smoking gun" for Alzheimer's disease treatment.
|
|
July 25 2005
The Key to a Healthy Heart Researchers at the University of Alberta (Edmonton, AB) have uncovered an important difference between healthy and failing hearts.
|
|
July 19 2005
Allergy and Asthma Sufferers May Have Lower Brain Cancer Risk A study released by researchers at Ohio State University (Columbus, OH) suggests that people who suffer from asthma, hay fever or other allergic conditions may be at a lower risk for the most common type of brain cancer.
|
|
July 12 2005
Mechanism Behind Cancer-preventing Foods Discovered Researchers appear to have discovered the mystery behind the cancer-prevention properties of certain foods.
|
|
July 05 2005
Low-weight Babies More Likely to Suffer Depression A new study conducted by U.K. researchers suggests that full-term babies who weigh less than 5.5 pounds at birth are more likely to suffer depression later in life.
|
|
June 13 2005
Elucidating the Genetics of Hypertension Research on the genetics of high blood pressure (hypertension) may benefit future diagnosis of the condition.
|
|
May 10 2005
Drug May Give Users Safe Mental Boost Love the boost you get from your morning cup of coffee, but hate the jittery side-effects caused by too much caffeine?
|
|
May 03 2005
Dementia Linked With Middle-age Obesity A bulging waistline may not be the only reason to watch ones weight during mid-life, according to a study by researchers at non-profit health plan provider Kaiser Permanente (Oakland, CA).
|
|
April 25 2005
Mothers May Pass on Propensity for Obesity, Diabetes in the Womb Mothers who suffer from obesity or diabetes may predispose their children to the same conditions in utero, according to recent studies conducted at the University of Buffalo (UB) (Buffalo, NY).
|
|
April 19 2005
Chocolate Could Hold Key to New Cancer Treatments The mechanism behind the anticancer properties of chocolate may have been uncovered by researchers at Georgetown University (Washington, DC).
|
|
April 12 2005
U of T Cancer Study ID's Regulator Molecule Researchers at the University of Toronto (Toronto, ON) have discovered a molecule that may be vital to the regulation of a well-known tumour suppressor.
|
|
March 28 2005
Surface Skin Cells May Contribute to Aging Process A new discovery by researchers at Potsdam, N.Y.-based Clarkson University has shown that aging could be more than just skin deep.
|
|
March 15 2005
Pre-heart Attack Electrical Changes Identified An undergraduate student and a research assistant professor from Johns Hopkins Universitys (Baltimore, MD) school of medicine have discovered that electrical changes in the heart can precede a heart attack long before it happens.
|
|
March 07 2005
McGill Researchers Make Major Cancer Discovery A team of researchers led by Dr. Jeremy R. Jass, Canada Research Chair in Gastrointestinal Pathology at McGill University (Montreal, QC), has discovered that certain cases of colorectal cancer can be inherited.
|
|
February 28 2005
Drinking Coffee May Lower Risk for Liver Cancer That daily cup of coffee could be doing more than giving you a welcome wake-up jolt, according to a 10-year study analysed by a team at the National Cancer Center in Tokyo, Japan.
|
|
February 21 2005
Researchers Discover New Stem Cell Source Researchers from the University of Toronto (Toronto, ON) have uncovered a new source for stem cells.
|
|
February 14 2005
Molecule Found in Afterbirth May Enhance Maternal Behaviour An opioid-enhancing molecule found in the amniotic fluid and afterbirth of mammals may help trigger an animal's maternal instinct.
|
|
February 08 2005
Vision-related Migraine Auras May Increase Female Stroke Risk Women who suffer vision problems commonly related to migraines are more likely to suffer an ischemic stroke, according to results of a study cited by researchers at the American Stroke Association (Dallas, TX) International Stroke Conference.
|
|
January 31 2005
Protein Linked to Increased Risk of Heart Disease A recent study shows that reduced levels of the protein adiponectin appear to indicate an increased risk of cardiovascular disease in patients with Type 1 diabetes.
|
|
January 17 2005
Heavy Drinking May Increase Male Risk of Stroke Those first two glasses of wine may be good for your heart, but U.S. researchers say a third might greatly increase your chances of suffering a stroke.
|
|
January 13 2005
Genetic Marker May Aid Fight Against HIV A team of researchers with the Howard Hughes Medical Institute (Chevy Chase, MD) has identified a group of immune system molecules that helps determine a person's resistance to infection with the AIDS virus.
|
|
January 13 2005
Combining Exercise with Eating Plant Oils to Reduce Heart Disease Risk Looking to lower your risk of heart disease? A combination of keeping fit and eating plant-derived sterols may do the trick.
|
|
January 10 2005
Non-opioid Drugs Effectively Reduce Morphine Intake Patients who have undergone chest or abdominal surgery may be able to reduce their morphine intake by adding two non-opioid drugs into their treatment plan.
|
|
November 15 2004
Protein Has Potential To Prevent Tumour Growth A pair of researchers from the University of Bristol (Bristol, U.K.) has discovered that a type of protein found in normal tissue has the potential to prevent tumour growth.
|
|
October 16 2004
Solvents May Pose Risk to Fetus Jobs in which expectant mothers are exposed to organic solvents may pose a threat to baby as well.
|
|
September 13 2004
Longevity-enhancing Effects of Bacterial Exposure in Fruit Flies By Deborah Komlos Bacterial exposure can increase longevity, but only when it occurs early in life.
|
|
September 07 2004
Blood Stem Cell Identified by Robarts Scientists Robarts Research Institute (London, ON) scientists have made the first identification of a specific cell subpopulation that gives rise to both the lining of blood vessels and to blood itself.
|
|
August 23 2004
YOUR DOSE or Mine? By Deborah Komlos ENABLING TECHNOLOGIES OFFER PROMISE TO ADVANCE MEDICINE TOWARD PERSONALIZED CARE
|
|
August 16 2004
Pinpointing the Source of Adult Shyness Adult shyness may stem from a change in production level of a stress hormone during pre-adolescence.
|
|
August 09 2004
Influenza Exposure During Pregnancy Increases Schizophrenia Risk Getting the flu while pregnant may not only make mom feel bad it may also pose health risks to baby.
|
|
July 12 2004
$1.3M U of S Study Probes Osteoporosis Prevention The Canadian Institutes of Health Research (CIHR) (Ottawa, ON) has awarded researchers at the University of Saskatchewan (U of S) (Saskatoon, SK) $1.3 million for an osteoporosis prevention study.
|
|
July 05 2004
Predicting Menopause Prospective mothers may now have a better handle on their biological clocks, thanks to a new assessment procedure.
|
|
June 07 2004
High Dose of Vitamin C May Worsen Osteoarthritis Researchers from the Duke University Medical Center (Durham, NC) have discovered from their study on guinea pigs that long-term, high doses of vitamin C may worsen osteoarthritis.
|
|
May 31 2004
Prostate Cancer Found in Men with Normal Screening Results Results of a study published last week in the New England Journal of Medicine indicate that about 15 per cent of men who scored within the acceptable range on a prostate-specific antigen (PSA) test did, in fact, have prostate cancer.
|
|
May 31 2004
Compound in Red Wine Can Kill Cancer Cells Scientists at the University of Virginia Health System (Charlottesville, VA) have unlocked the secrets of resveratrol - the compound that is credited with providing the health benefits associated with moderate red-wine consumption.
|
|
May 03 2004
Stem Cells Help Heart Function Patients with congestive heart failure may one day have a new treatment to improve their heart function: an injection of adult stem cells into their damaged heart tissue.
|
|
April 26 2004
Gene Plays Role in Asthma Researchers from McGill University's Genome Quebec Innovation Centre (Montreal, QC) and the University of Helsinki (Helsinki, Finland) have identified two genes that appear to be associated with an increased risk of developing asthma.
|
|
April 19 2004
Parkinsons' Disease Gene Identified Scientists at University College London's Institute of Neurology (London, U.K.) have discovered a gene that is linked to a familial form of Parkinson's disease.
|
|
April 12 2004
Discovery for Rett Syndrome to Spur Diagnostic Test A new molecular test may soon detect Rett syndrome, thanks to a discovery that has revealed a new form of the disease gene associated with the neurological disorder.
|
|
March 29 2004
Intestinal Parasite Genome Sequenced The newly sequenced genome of an intestinal parasite may lead to new ways to treat and prevent infection.
|
|
March 29 2004
Canadian Researchers First to Create Lab-induced T-Cells A feat that has eluded scientists in the past is now a triumph for a team at the University of Toronto (U of T) (Toronto, ON): the successful in vitro generation of immune system cells.
|
|
March 22 2004
Blood-vessel Growth Augmented by Fat Cells Fat-derived cells may find a future in improving blood-vessel growth, and therefore, blood circulation.
|
|
March 15 2004
Diabetes Risk Reduced with Coffee A cup of coffee a day may keep diabetes away.
|
|
February 09 2004
Avian Flu Raises Cause for Concern The avian influenza is the latest health issue to elicit concern over new pandemic infections in humans.
|
|
February 02 2004
Mouse Study Targets Enzyme in Alzheimer's Memory Loss Northwestern University scientists prevented learning and memory deficits in a study using knockout mice bred to lack an enzyme that produces the "senile plaques" in the brain that indicate Alzheimer's disease.
|
